Newsfeeds Archive - Spark Newswire

1 minute read

September 11, 5:58 AM

Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its

SVA

3 minute read

Jim Cramer Says China’s Vaccines ‘Don’t Work’ But Xi Won’t Admit It

By Adam Eckert

November 22, 3:45 PM

COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.

BNTX

1 minute read

SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile

By Bill Haddad

September 6, 6:01 AM

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institute (Instituto de Salud

SVA

Latest news

SINOVAC Updates on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection

Jim Cramer Says China’s Vaccines ‘Don’t Work’ But Xi Won’t Admit It

SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile